The risk of malignancy is weighed against the attendant risks of surgery in the clinical management of pancreatic cysts. The latter are a group of histologically diverse and prognostically variable entities, and the risk of malignancy therein is primarily based on imaging characteristics-with or without high-grade atypia. Cytologic criteria for high-grade atypia in intraductal papillary mucinous neoplasms have recently been defined, and its recognition in all pancreatic cysts may help to guide management. METHODS: All patients who underwent endoscopic ultrasound-guided fine-needle aspiration for a pancreatic cyst at Massachusetts General Hospital from June 2015 to October 2016 were prospectively evaluated. Clinical data, radiographic impressions, biochemical analyses, and cytologic diagnoses of 118 pancreatic cyst fine-needle aspiration biopsy specimens from 106 patients were reviewed. Clinical and radiologic data were used as follow-up for 86 patients, and histology was obtained in 20 cases. Cysts were classified by imaging as highrisk, worrisome, or low-risk as defined by the 2012 Fukuoka consensus guidelines. Cytology was categorized as lowgrade or high-grade. Malignant histology included mucinous cysts with high-grade dysplasia, invasive adenocarcinomas, and neuroendocrine tumors. The risk of malignancy (ROM) was determined by histological outcome. RESULTS: The presence of high-grade cytology (P < .01) was the only statistically significant predictor of malignancy and was 89% sensitive and 98% specific for malignancy. The positive predictive value (ie, ROM) of high-grade atypia on cytology was 80%. CONCLUSIONS: High-grade atypia is both sensitive and specific for identifying high-risk pancreatic cysts and is associated with a high risk of malignancy, and thus resection is warranted. Cancer Cytopathol 2018;126:773-781.
INTRODUCTION
Cystic lesions of the pancreas include a variety of benign and malignant lesions and can pose a clinical conundrum. A multidisciplinary, multimodal approach is essential for the preoperative evaluation of patients with pancreatic cysts. The management of these patients depends on several factors. The treatment approach, however, chiefly depends on whether the cyst is mucinous or nonmucinous and benign or malignant. Mucinous cysts, which include intraductal papillary mucinous neoplasms (IPMNs) and mucinous cystic neoplasms, are lined with dysplastic epithelium and carry a risk of malignancy. In the preoperative evaluation of pancreatic cysts, radiologists and cytopathologists strive to accurately distinguish clinically aggressive mucinous cysts, which should be surgically managed, from those that could be conservatively followed with increased imaging surveillance.
International guidelines have been issued to assist in guiding the preoperative management of pancreatic cysts. The most recent of these is the 2012 Fukuoka consensus guidelines. 1 On the basis of these guidelines,
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IPMNs are stratified into 3 risk groups almost entirely according to imaging characteristics. The detection of either high-risk stigmata or worrisome features warrants either resection or increased surveillance (Table 1) . These 2012 guidelines, however, are only modestly sensitive and specific for identifying malignant lesions. [2] [3] [4] Endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) offers a safe, sensitive, specific, and swift method for evaluating cystic pancreatic lesions. Cytologic examinations and biochemical and molecular analyses of aspirated material provide information crucial for an accurate diagnosis. [5] [6] [7] [8] In 2014, Pitman et al 9 identified 5 cytologic criteria for diagnosing high-grade atypia in IPMNs, which represent high-grade dysplasia or adenocarcinoma on histology ( Table 2 ). The group found that the 3 most accurate features for the identification of high-grade atypia were background necrosis, an abnormal chromatin pattern, and an increased nuclear-to-cytoplasmic ratio ( Fig. 1 ). Using the criteria for high-grade atypia from the previous study, we assessed its diagnostic value in determining malignancy in a prospective cohort of patients with any pancreatic cyst evaluated by EUS-FNA.
MATERIALS AND METHODS
All patients who underwent EUS-FNA for a pancreatic cyst at Massachusetts General Hospital from June 2015 to October 2016 were prospectively evaluated. Clinical data, including the age and sex of patients and the presence of obstructive jaundice, were recorded. Radiographic reports, including computerized tomography (CT), magnetic resonance imaging (MRI), and endoscopic ultrasound (EUS), were reviewed via electronic medical records. The location and size of aspirated pancreatic cysts were recorded with EUS, CT, and MRI data. The cysts were classified by imaging as high-risk, worrisome, or low-risk as prescribed by the 2012 guidelines (Table 1) . All pancreatic cyst fluids were submitted for evaluation in their fresh and undiluted state. All cytologic materials reviewed were made with cytospin preparations (Thermo-Shandon Instruments, Asheville, North Carolina). Epithelial cells were classified on cytology as either low-grade or high-grade. As established by Pitman et al, 9 the assessed cytologic features included the following parameters: cell size (smaller than, equal to, or larger than a 12-µm duodenal enterocyte), nuclear-to-cytoplasmic ratio (increased or normal), nuclear membrane irregularities (marked, minimal, or none), chromatin pattern changes (hyperchromatic or normochromatic), and background cellular necrosis (present or absent). Low-grade was defined as the presence of low-grade mucinous epithelium or serous epithelium, whereas high-grade denoted mucinous epithelium demonstrating high-grade atypia or worse (ie, adenocarcinoma or neuroendocrine tumor).
The criteria for the minimum number of examined cells in pancreatic cyst fluid cytology have not been established. All cytologic samples that were classified as high-grade cytology displayed, to variable degrees, the features listed in Table 2 within viable cells present. When a constellation of high-grade atypical features was present in sufficient quality and quantity, the diagnosis of adenocarcinoma or neuroendocrine tumor was rendered. Cancer Cytopathology September 2018
The histologic grading of mucinous cysts was determined by the highest grade of dysplasia. Cysts with nonmucinous features or mucinous epithelium with low-to intermediate-grade dysplasia on histology were considered benign. Mucinous cysts with high-grade dysplasia, an adenocarcinoma, or a neuroendocrine tumor on resection were classified as malignant. In addition to a microscopic evaluation, aliquots of pancreatic cyst fluid were also submitted for the testing of carcinoembryonic antigen (CEA) and amylase levels. Results of biochemical analyses for CEA and amylase were not used for the risk assessment of pancreatic cysts.
In cases without histology, the cytologic classification of a low-grade cyst was considered accurate if the clinical or radiologic impressions were also benign or if no malignancy was detected within 12 months of diagnosis. The positive predictive value was determined by histologic outcomes. Comparisons between categorical variables were determined with the chi-square test and Fisher's exact test. Differences between groups in noncategorical Cancer Cytopathology September 2018 variables were assessed with the Student t test. Statistical significance was established at P = .05. This study was conducted under institutional review board approval.
RESULTS
During the study period, 118 pancreatic cyst EUS-FNA biopsy specimens were obtained from 106 patients. Our study cohort is summarized in Figure 2 . Clinical, radiographic, biochemical, and cytologic findings of these cases with histology are described in Table 3 . The study group consisted of 59 women (55.7%) and 47 men (44.3%). Patients' ages ranged from 20 to 91 years (mean for women, 63 years; mean for men, 67 years). According to the 2012 guidelines, 65 cysts (55.1%) were classified as low-risk, 48 (40.7%) were classified as worrisome, and 5 (4.2%) were classified as high-risk. One hundred one pancreatic cyst FNA samples (85.6%) were adequate for cytologic evaluation, and 17 (14.4%) were nondiagnostic. Eighty-nine specimens (88.1%) showed lowgrade cytology, and 12 (11.9%) had high-grade cytology. There were 72 mucinous cysts (61%) in our study. Of these, 51 (70.8%) were low-grade, 9 (12.5%) were high-grade, and 12 (16.7%) were nondiagnostic. Clinical and radiologic data were used for follow-up in 86 patients. Twenty pancreatic cysts (16.9%) had concurrent histology available. Eleven of these cases (55%) with histology revealed a benign process, and 9 (45%) harbored malignancy. Ultimately, when the nondiagnostic cases were excluded, there were 8 true-positive cases, 90 true-negative cases, 2 false-positive cases, and 1 false-negative case in our study cohort.
Overall Diagnostic Performance
The presence of high-grade cytologic features was the only statistically significant distinguishing characteristic that supported malignancy (P < .01). The identification of high-grade atypia on EUS-FNA was 89% sensitive and 98% specific for malignancy. The risk of malignancy, or the positive predictive value, with these findings was 80%. The negative predictive value was 98.9%.
Cyst Fluid Analysis
CEA and amylase levels were obtained from pancreatic cyst fluid samples: 113 (95.8%) and 114 (96.6%), respectively. Mucinous pancreatic cysts were found to have higher mean CEA levels than nonmucinous cysts (2713.0 and 11.1 ng/mL, respectively; P = .41), whereas nonmucinous cysts had greater mean levels of amylase in comparison with mucinous cysts (98,410.8 and 63,415.2 U/L, respectively; P = .94). Malignant pancreatic cysts had higher mean CEA and amylase levels than their benign counterparts, although neither showed a statistically significant difference between the 2 groups (Table 3) .
Radiologic-Cytologic Correlation
Radiographically low-risk pancreatic cysts (n = 65) demonstrated low-grade cytology in 53 cases (81.5%), high-grade cytology in 2 cases (3.1%), and nondiagnostic samples in 10 cases (15.4%). Within this group of radiologically low-risk cysts, histology was available for 2 cases (3.1%). Both cases displayed high-grade cytology and are detailed later in the Clinicopathological Discordant Cases section.
Cysts with worrisome imaging features (n = 48) showed low-grade cytology in 35 cases (72.9%) and highgrade cytology in 6 cases (12.5%) and were nondiagnostic in 7 cases (14.6%). Histology was obtained in 13 cases (27%; discussed in the Cytohistological Correlation section). 
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Radiologically high-risk cysts (n = 5) displayed lowgrade cytology in 1 case (20%) and high-grade cytology in 4 cases (80%), and there were no nondiagnostic samples. Histology was available in all 5 cases (see the Cytohistological Correlation and Clinicopathological Discordant Cases sections).
Overall, radiologic and cytologic impressions of the pancreatic cysts in our study cohort were concordant in 56 of 101 diagnostic samples (55.4%; Fig. 2 ). In these cases, clinical and histopathologic follow-up also agreed with radiologic and cytologic impressions. In 3 of the 101 diagnostic cytologic specimens (3%), radiology and cytology disagreed in their assessment (Fig. 2) . These discordant cases are further discussed in the Clinicopathological Discordant Cases section.
Cytohistological Correlation
Of the 20 cases with available histology, 9 (45%) were malignant neoplasms, and 11 (55%) were benign lesions. Overall, high-grade cytologic atypia was found in 4 malignant cysts and 1 benign cyst (discussed later).
For malignant pancreatic cysts, there was a strong predilection for older men (male-to-female ratio, 3.5:1), with a mean age of 66 years (range, 48-88 years). These lesions most commonly were found in the pancreatic head (n = 7; 77.8%). Malignant cysts had a mean size of 28 mm (range, 5-60 mm). Four malignant cysts (44.4%) were classified as high-risk on imaging, 4 (44.4%) were classified as worrisome, and 1 (11.2%) was classified as lowrisk. The last was subsequently found to have high-grade cytology by EUS-FNA and showed adenocarcinoma on histology (see the Clinicopathological Discordant Cases section).
Malignant pancreatic cysts were found to harbor high-grade cytology in 8 cases (88.9%) and low-grade cytology in 1 case (11.1%). The histopathology of these 9 cysts showed 6 cases of pancreatic adenocarcinoma (66.7%), 2 cases of well-differentiated neuroendocrine tumors (22.2%), and 1 case of a main-duct IPMN with high-grade dysplasia (11.1%). In 6 cases of adenocarcinoma, cystic degeneration was noted; in the remaining 3 cases of adenocarcinoma, invasive carcinoma derived from IPMNs with high-grade dysplasia was found.
Benign cysts occurred more often in women (female-to-male ratio, 1.75:1), with a mean age of 60 years (range, 20-83 years). These lesions were evenly distributed throughout the head, body, and tail of the pancreas. Benign cysts tended to be larger than malignant cysts, with a mean size of 36 mm (range, 12-60 mm). Radiologically, 1 benign cyst (9.1%) was classified as high-risk, 9 (81.8%) were classified as worrisome, and 1 (9.1%) was classified as low-risk. The lone benign cyst with high-risk stigmata by imaging displayed mucinous epithelial cells with low-grade atypia on cytology and a combinedtype IPMN with intermediate-grade dysplasia on histology.
Benign cysts had low-grade cytology in 8 cases (72.7%) and high-grade cytology in 2 cases (18.2%) and were nondiagnostic in 1 case (9.1%). In all, the 11 benign cysts showed an IPMN with low-or intermediate-grade dysplasia in 6 cases (54.5%), a mucinous cystic neoplasm with intermediate-grade dysplasia in 2 cases (18.2%), a serous cystadenoma in 1 case (9.1%), an acinar cell Cancer Cytopathology September 2018 cystadenoma in 1 case (9.1%), and an endometriotic cyst (within the distal pancreas) in 1 case (9.1%).
No clinical or radiologic features were found to have a statistically significant predictive value in detecting malignant pancreatic cysts (Table 3) .
Clinicopathological Discordant Cases
EUS-FNA results conflicted with radiologic classification in 3 cases (3%). From a cytologic standpoint, there were 2 false-positive cases (2%) and 1 false-negative case (1%).
Two pancreatic cysts (2%) were classified as lowrisk by imaging and displayed high-grade cytology. Ultimately, histology proved 1 case benign and 1 case malignant. In the latter case, a 58-year-old man with a history of cystic fibrosis presented with increased loose stools and weight loss. A pancreatic cyst was discovered on imaging. EUS showed a small, 17-mm pancreatic head cyst, which was deemed low-risk according to the 2012 guidelines. EUS-FNA biopsy displayed high-grade atypia in mucinous epithelium that was consistent with a high-grade IPMN (Fig. 3) . The patient underwent a Whipple resection, which showed an invasive adenocarcinoma derived from a branch-duct IPMN with highgrade dysplasia (Fig. 3) .
The other low-risk radiology, high-grade cytology case involved a 65-year-old woman who presented with epigastric pain. This case constituted 1 of the 2 false-positive cases for cytology. EUS showed a 28-mm cystic lesion of the pancreatic body without high-risk or worrisome features. Radiographic studies suggested a branchduct IPMN. EUS-FNA biopsy showed a hypercellular specimen composed of mucinous epithelial cells with a high nuclear-to-cytoplasmic ratio and some nuclear membrane irregularities, which were consistent with an IPMN with high-grade atypia (Fig. 4) . The pancreatic cyst fluid CEA level was 1.2 ng/mL. Three months later, repeat EUS-FNA with concurrent Moray microforceps biopsy of the growing cyst was diagnostic of acinar cell cystadenoma. 10 Immunoreactivity for trypsin and chymotrypsin, nonimmunoreactivity for synaptophysin, and a low Ki-67 index supported the diagnosis. Distal pancreatectomy confirmed the diagnosis of acinar cell cystadenoma (Fig. 4) . There was 1 radiographically high-risk, cytologically low-grade pancreatic cyst (1%). An 81-year-old woman presented to her primary care physician with unintentional weight loss and diarrhea. Her symptoms prompted a CT scan, which revealed a 4-cm cystic pancreatic head mass. A 2-cm, dilated main pancreatic duct, a high-risk imaging feature, was identified. EUS-FNA, however, showed cytologically low-grade glandular mucinous epithelium with intermediate-grade dysplasia. A Whipple procedure was performed because of the large size of the lesion. Histology demonstrated a combined-type IPMN with intermediate-grade dysplasia.
There were 2 false-positive cytology cases (2%); the first was discussed previously. The second case was a 74-year-old man who presented with epigastric discomfort. MRI and EUS revealed a worrisome 33-mm, anechoic, thin-walled pancreatic head cyst and a 6-mm, dilated main pancreatic duct. EUS-FNA showed groups of disorganized and mitotically active small glandular cells with apical mucin, which were consistent with a mucinous cyst with intermediate-to high-grade atypia (Fig. 5) . On Whipple resection, a 35-mm predominantly branch-duct IPMN with intermediate-grade dysplasia Cancer Cytopathology September 2018 extending into the main pancreatic duct was diagnosed (Fig. 5) .
The 1 false-negative cytology case (1%) was that of a 63-year-old woman with a history of acute pancreatitis. Imaging showed a worrisome cyst in the pancreatic head. EUS-FNA showed rare, poorly preserved atypical epithelioid cells, and the case was categorized as atypical. Six months after the initial presentation, pancreatic duct brushings and a subsequent Whipple procedure both showed an adenocarcinoma.
DISCUSSION
In this study, we determined the diagnostic value of highgrade cytologic atypia in pancreatic cyst cytology for stratifying the risk of malignancy. Our findings showed that the identification of high-grade cytology was the only statistically significant predictor of malignancy. None of the following showed statistically significant differences between benign and malignant pancreatic cysts in our study cohort: patient's age or sex, cyst size, cyst location, imaging classification, or biochemical analyses. High-grade cytologic atypia was 89% sensitive and 98% specific for malignancy. The positive and negative predictive values of high-grade atypia were 80% and 98.9%, respectively.
Current management guidelines for patients with pancreatic cysts heavily rely on radiographic impressions for guiding patient care, 1 but the ability of imaging, whether it be CT, MRI, or EUS, to detect high-risk cysts with premalignant (ie, noninvasive) pathology is poor.
11
High-risk imaging features generally indicate an invasive carcinoma, at which point the patient's prognosis is halved. 3, 12 The ideal time for surgical management is when the cyst has carcinoma in situ or high-grade dysplasia. The accurate diagnosis of a cyst with high-grade cytology, however, is a challenge.
We have shown that cytology can correlate with the histologic grade in IPMNs in a previous study. 13 We have also recognized atypical epithelial cells in pancreatic cyst fluid as being an indicator of a high-risk cyst in a separate publication. 14 Therein, we demonstrated that atypical epithelial cells were a high-risk feature for malignancy in IPMNs with a sensitivity of 72%, a specificity of 85%, and an accuracy of 80%, with similar values for small (<3-cm) branch duct IPMNs as well. Since then, we have refined the diagnostic criteria for high-grade atypia and shown that 1) a small cell size in comparison with a 12-μm duodenal enterocyte, 2) an increased nuclear-to-cytoplasmic ratio, 3) marked nuclear membrane irregularities, 4) an abnormal chromatin pattern, and 5) background cellular necrosis distinguish high-grade atypia from low-grade neoplasms with low-to intermediate-grade dysplasia. 9, 15 This study is the first to assess the risk of malignancy of high-grade atypia prospectively diagnosed by EUS-FNA of pancreatic cysts. Most of the patients in this study had worrisome imaging features, and most of these had low-grade cytology (77%) and thus avoided surgery. Of the 48 patients in this group, 13 (27%) did go on to surgery, with 1 false-positive high-grade atypia and 1 false-negative cytology. Of the 65 patients with low-risk imaging features, 2 were found to have high-grade atypia, with 1 confirmed malignancy and 1 false-positive high-grade atypia.
A false-positive high-grade diagnosis is more of an issue in the evaluation of pancreatic cyst cytology than Cancer Cytopathology September 2018 false-negative cytology because imaging features tend to be discordant with negative cytology in patients with malignancy. Rounding up and degeneration of low-grade cells can mimic high-grade atypia. One such mimicker is highlighted by a case of acinar cell cystadenoma, an exceedingly rare benign cystic lesion of the pancreas. The small cells with a high nuclear-to-cytoplasmic ratio of acinar cell cystadenomas fit the criteria for high-grade atypia. 16, 17 The discordance between the low-risk imaging, the high-grade cytology, and the relatively young age of the patient led to repeat sampling with the microforceps biopsy, which provided a small histological sample that allowed for immunohistochemical confirmation of the diagnosis. 10 As described by Pitman et al, 9 there are several challenges in the cytologic grading of pancreatic cyst fluid. The variety of neoplastic cell types and the varying degrees of reactive atypia and degeneration displayed contribute to the difficulty in cytologic interpretation. Furthermore, the classification of high-grade atypia is a nonspecific high-risk category that attempts to encompass overlapping histological findings of high-grade dysplasia, adenocarcinoma, and neuroendocrine tumors. Even still, cysts bearing the cytologic diagnosis of high-grade atypia may ultimately show no evidence of malignancy. In addition, interobserver variation will invariably occur. To this end, as illustrated by Pitman et al, 15 a 2-tiered low-and high-grade classification system demonstrates very good interobserver concordance, particularly in comparison with a 5-tiered grading system. With these limitations in mind, one should regard the cytologic examination of pancreatic cyst fluid as a screening test for malignancy. 9 Despite these limitations, in this study, we have found that recognition of high-grade epithelial atypia is an important, statistically significant predictor of cysts at risk of malignancy. Just as important as the recognition and diagnosis of high-grade atypia are for the surgical triage of patients is understanding that the absence of high-grade cytology provides support for conservative management. Previously, we have shown that the triple-negative findings of no high-risk stigmata, no worrisome features, and no high-grade atypia on cytology provide a negative predictive value of 99% for malignancy, and this allows for confident conservative management. 8 Our data in the current study validate that stance. No patient with lowrisk imaging and negative cytology had clinicopathological evidence of a malignant cyst. In fact, 1 patient with low-risk imaging had high-grade atypia on cytology, with the resection ultimately confirming malignancy. Our nondiagnostic rate was 14.4%, which is within the reported range of 5.8% to 25.8%. [18] [19] [20] The relatively high nondiagnostic rate of pancreatic cysts can be attributed to the cystic nature of these lesions, the viscidity of the contents, the degenerative nature of cells in cyst fluid and technical limitations. 19, 21 In our study, samples were most commonly nondiagnostic because of scant cellular material.
The main drawback of our study was the limited histological follow-up. Most patients in our cohort had cysts that were low-risk by imaging and low-grade by cytology, and both factors support conservative management with imaging surveillance rather than surgical management. In addition, 2 study patients with high-grade cytology were found to have advanced disease, which precluded surgical resection.
In summary, our prospective study of 118 pancreatic cysts demonstrates the importance of the evaluation of pancreatic cyst fluid cytology for high-grade atypia on cytologic evaluation. The presence of high-grade cytologic atypia was the only statistically significant predictor of malignancy and was highly sensitive and specific for a high-risk cyst with a risk of malignancy of 80%, and thus surgical management was warranted.
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